Avalon Ventures

This venture capital firm invests in seed and early-stage companies in wireless communications, Web 3.0 digital media, and life sciences, primarily focusing ...

ActiveVenture Capital

Updated: Feb 17, 2026 ·

About

Avalon Ventures is a San Diego and Boston-based venture capital fund, currently investing Avalon Ventures VIII, LP, which has $150 million under management. The fund primarily focuses on seed and early development stage companies in the wireless communications, Web 3.0 digital media, and life science industries. The firm has a geographic investment focus on companies based in California and the Northeast. Avalon does co-invest in certain circumstances with firms such as Kleiner Perkins Caufield & Byers (12 deals) and Versant Ventures (11 deals).

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 1, 2025	Joy	$14.0M Series A	—	Altair Capital Management, Dream Machine, Forerunner Ventures, General Catalyst, Helium-3 Ventures, Liquid 2 Ventures, Magnify Ventures, NFX, Polychain Capital, SNR, Sound Ventures, Timespan Ventures, Eduardo Haber, Justin Timberlake, Louis Beryl, Mark Pincus, Matt Bellamy, Stacy Brown-Philpot
Oct 1, 2025	AeroRx Therapeutics	$21.0M Series A	—	Frazier Healthcare Partners, OrbiMed, Samsara BioCapital
Nov 1, 2024	Pep2Tango Therapeutics	$1K Venture Round	—	Polaris Partners, Versant Ventures
Nov 1, 2024	Leland	$12.0M Series A	—	Altair Capital Management, Contrary Capital, Dream Machine, FirstHand Alliance, Forerunner Ventures, General Catalyst, Crystal Huang, Helium-3 Ventures, Khosla Ventures, Lightspeed Venture Partners, Liquid 2 Ventures, Magnify Ventures, NFX, Oceans, Polychain Capital, RTP Global, SNR, Sound Ventures, Spark Capital, Timespan Ventures, WorkLife Ventures, Y Combinator, Derrick Li, Eduardo Haber, Emmett Shear, Guillaume Roux-Romestaing, Justin Timberlake, Louis Beryl, Mark Pincus, Matt Bellamy, Michael Ma, Stacy Brown-Philpot
Jul 1, 2024	Halo Industries	$80.0M Series B	—	11, 11k Ventures, Accel, Addition, Alumni Ventures, Applied Ventures, Craft Ventures, Dimension Capital, Founder Collective, Founders Fund, Haun Ventures, ICONIQ Capital, Innovation Endeavors, In-Q-Tel, Jetstream, Khosla Ventures, LGF, Lockheed Martin Ventures, Long Journey Ventures, Paradox Capital, Primer Sazze Partners, Sequoia Capital, Starframe Capital, The Hit Forge, Trajectory Ventures, Walden International, XStarPartners, Amjad Masad, Anna Yuan, Bradley Horowitz, David Mytton, Guillaume Lestrade, Julie Zhuo, Oleg Rogynskyy, Omar El-Ayat, Sahin Boydas, Sam Altman, Saturnin Pugnet, Tobias Lutke, Tony Xu, Young Song
Jul 1, 2024	Heartbeat Health	$25.0M Series C	—	.406 Ventures, Ascension Ventures, Echo Health Ventures
Apr 1, 2024	FloQast	$100.0M Series E	—	11, 9Yards Capital, Accel, Addition, Craft Ventures, Dimension Capital, Founder Collective, Founders Fund, Haun Ventures, ICONIQ Capital, In-Q-Tel, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, Meritech Capital Partners, Norwest Venture Partners, Paradox Capital, Polaris Partners, Primer Sazze Partners, Sequoia Capital, The Hit Forge, Toba Capital, Andy Cohen, World Innovation Lab, XStarPartners, Amjad Masad, Anna Yuan, Bradley Horowitz, David Mytton, Guillaume Lestrade, Julie Zhuo, Mo El-Bibany, Oleg Rogynskyy, Omar El-Ayat, Sam Altman, Tobias Lutke, Tony Xu, Young Song
Apr 1, 2024	Enlaza Therapeutics	$100.0M Series A	—	.406 Ventures, Ascension Ventures, Atlas Venture, Frazier Healthcare Partners, OrbiMed, Samsara BioCapital
Feb 1, 2024	Galileo AI	$4.0M Seed	—	11, Accel, Addition, Benchmark, C2 Investment, Caffeinated Capital, Coatue, Craft Ventures, Dimension Capital, Founder Collective, Founders Fund, Haun Ventures, ICONIQ Capital, In-Q-Tel, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, No Label Ventures, Operator Collective, Paradox Capital, Primer Sazze Partners, Project A, Sequoia Capital, The Hit Forge, XStarPartners, Amjad Masad, Anna Yuan, Bradley Horowitz, Chris Cheng, David Mytton, Felipe Navio, Guillaume Lestrade, Oleg Rogynskyy, Omar El-Ayat, Sam Altman, Scott Belsky, Tobias Lutke, Tony Xu, Young Song
Feb 1, 2024	Matter Neuroscience	$26.0M Seed	—	ARCH Venture Partners, Broadview Ventures, Polaris Partners, Versant Ventures
Sep 1, 2023	Pixis	$85.0M Series C	—	Airtree Ventures, Amasia, Amplify Partners, Audrey Capital, Cedar Capital Group, Celesta, Dell Technologies Capital, Five Sigma, Fuel Capital, Genoa Ventures, Heavybit, IDG Ventures, Madrona Ventures, Alexander Rosen, Gil Penchina, Salesforce Ventures, Softbank Group, SoftBank Investment Advisers, Tiger Global Management, Vertex Ventures, Alex Payne, Eric Ries, Jeremy LaTrasse, Kyle York, Mark Williamson
Sep 1, 2023	Arialys Therapeutics	$58.0M Seed	—	—
Jul 1, 2023	Solvook	$5.0M Series A	—	11, Accel, Addition, Craft Ventures, Dimension Capital, Founder Collective, Founders Fund, Haun Ventures, ICONIQ Capital, In-Q-Tel, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, Paradox Capital, Primer Sazze Partners, Sequoia Capital, The Hit Forge, XStarPartners, Amjad Masad, Anna Yuan, Bradley Horowitz, David Mytton, Guillaume Lestrade, Julie Zhuo, Oleg Rogynskyy, Omar El-Ayat, Sam Altman, Tobias Lutke, Tony Xu, Young Song
May 1, 2023	Triumph	$10.0M Series A	—	Kevin Hartz, Altair Capital Management, AME Cloud Ventures, Dream Machine, Floodgate, Forerunner Ventures, Founders Fund, General Catalyst, Hanabi Capital, Hardware Club, Helium-3 Ventures, Heroic Ventures, Liquid 2 Ventures, Magnify Ventures, NFX, Polychain Capital, Sherpalo Ventures, SNR, Sound Ventures, The Hit Forge, Timespan Ventures, Eduardo Haber, Justin Timberlake, Louis Beryl, Mark Pincus, Matt Bellamy, Sahin Boydas, Stacy Brown-Philpot, Stanley Druckenmiller
Feb 1, 2023	IgGenix	$40.0M Series B	—	11, Accel, Addition, Craft Ventures, Dimension Capital, Founder Collective, Founders Fund, Haun Ventures, ICONIQ Capital, In-Q-Tel, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, Paradox Capital, Primer Sazze Partners, Sequoia Capital, The Hit Forge, XStarPartners, Amjad Masad, Anna Yuan, Bradley Horowitz, David Mytton, Guillaume Lestrade, Julie Zhuo, Oleg Rogynskyy, Omar El-Ayat, Sam Altman, Tobias Lutke, Tony Xu, Young Song
Dec 1, 2022	Runway	$50.0M Series C	—	11, Accel, Addition, AirAngels, Amplify Partners, Andreessen Horowitz, Benchmark, Bond, C2 Investment, Coinbase Ventures, Contrary Capital, Cornerstone Venture Partners, Costanoa Ventures, Craft Ventures, Dimension Capital, Eclipse Ventures, Jenny Fielding, Scott Hartley, Felicis Ventures, First Round Capital, Foundation Capital, Founder Collective, Founders Fund, General Catalyst, Greenoaks Capital, Haun Ventures, ICONIQ Capital, In-Q-Tel, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, Meritech Capital Partners, Moonfire Ventures, Msd Capital, Next47, Next Play Ventures, Operator Collective, Otherwise Fund, Pace Capital, Paradox Capital, Predictive VC, Primer Sazze Partners, Primetime Partners, SciFi VC, Sequoia Capital, Seven Seven Six, The Hit Forge, Theory Ventures, Vertex Ventures, Weekend Fund, Work-Bench, XStarPartners, XYZ Venture Capital, Y Combinator, Adam Gross, Allison Pickens (Allison Pickens Ventures), Ameet Patel, Anna Yuan, Ben Silbermann, Bradley Horowitz, David Mytton, Gokul Rajaram, Guillaume Lestrade, Guillermo Rauch, Guy Podjarny, Jim Young, Julie Zhuo, Liu Jiang, Mike Vernal, Neha Narkhede, Oleg Rogynskyy, Omar El-Ayat, Sam Altman, Scott Belsky, Tim Kendall, Tim Sadler, Tobias Lutke, Tony Xu, Young Song
Nov 1, 2022	Jnana Therapeutics	$110.0M Series C	—	ARCH Venture Partners, Bison Ventures, Polaris Partners, RA Capital, Samsara BioCapital, SoftBank Investment Advisers, Versant Ventures
Oct 1, 2022	Enlaza Therapeutics	$61.0M Seed	—	.406 Ventures, Ascension Ventures, Atlas Venture, Frazier Healthcare Partners, OrbiMed, Samsara BioCapital
Aug 1, 2022	Maximus	$15.0M Series A	—	11, 8VC, Abstract Ventures, Accel, Addition, Anti fund, Bam Ventures, BITKRAFT Ventures, Caffeinated Capital, Craft Ventures, Dimension Capital, Fifth Down Capital, Founder Collective, Founders Fund, Friends & Family Capital, Griffin Gaming Partners, Haun Ventures, ICONIQ Capital, In-Q-Tel, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, Multicoin Capital, Norwest Venture Partners, Hans Tung, Paradox Capital, Polychain Capital, Polygon, Primer Sazze Partners, Sequoia Capital, Shine Capital, The Hit Forge, Ulu Ventures, XFactor Ventures, XStarPartners, Amjad Masad, Anna Yuan, Ben Perszyk, Bradley Horowitz, David Mytton, Gokul Rajaram, Guillaume Lestrade, Jake Kassan, Julie Zhuo, Kyle Widrick, Matteo Franceschetti, Oleg Rogynskyy, Omar El-Ayat, Prashant Malik, Ryan Holiday, Sam Altman, Tobias Lutke, Tony Xu, Young Song
Jul 1, 2022	Elation Health	$50.0M Series D	—	.406 Ventures, Ascension Ventures, Healthy Ventures, Charlie Cheever
Jun 1, 2022	Titan	$4.0M Seed	—	11, 3one4 Capital, 3VC, Kevin Hartz, Accel, Addition, Andreessen Horowitz, AngelList, Audrey Capital, Bombas, Craft Ventures, Dimension Capital, Dreamers VC, Electric Capital, Founder Collective, Founders Fund, Fusion Fund, General Catalyst, Haun Ventures, ICONIQ Capital, In-Q-Tel, Interlock Partners, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, MUFG Innovation Partners, NewFund, NFX, Hans Tung, Paradox Capital, Picus Capital, Primer Sazze Partners, Quiet Capital, Sapphire Ventures, Sequoia Capital, Signia Venture Partners, Silversmith Capital Partners, Sound Ventures, Team Ignite Ventures, The Finger Group, The Hit Forge, Thirty Five Ventures, Tiger Global Management, XStarPartners, Y Combinator, Zetta Venture Partners, Adrian Aoun, Amjad Masad, Anna Yuan, Brad Bao, Bradley Horowitz, David Fraga, David Mytton, Evan Moore, Guillaume Lestrade, Jared Leto, Joshua Reeves, Julie Zhuo, Kevin Weil, Mike Krieger, Odell Beckham Jr., Oleg Rogynskyy, Omar El-Ayat, Sam Altman, Tikhon Bernstam, Tobias Lutke, Tony Xu, Vinay Hiremath, Young Song
Jun 1, 2022	Neol	$5.0M Seed	—	11, Accel, Addition, Alumni Ventures, Andreessen Horowitz, Angel Labs, AV8 Ventures, Craft Ventures, Dimension Capital, Founder Collective, Founders Fund, Global Ventures, Haun Ventures, ICONIQ Capital, In-Q-Tel, Intel Capital, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, Madrona Ventures, Paradox Capital, Primer Sazze Partners, Rabbit Ventures, Sequoia Capital, Team Ignite Ventures, Ten Eleven Ventures, The Hit Forge, Village Global, XStarPartners, Amjad Masad, Anna Yuan, Bradley Horowitz, David Mytton, Guillaume Lestrade, Julie Zhuo, Oleg Rogynskyy, Omar El-Ayat, Portman Wills, Sam Altman, Tobias Lutke, Young Song
Jun 1, 2022	Pulley	$4.0M Seed	—	01 Advisors, 11, 75 & Sunny, Accel, Addition, Ascend Vietnam Ventures, BILL, Bond, C2 Investment, Conviction Partners, Craft Ventures, Kevin Ding, Dimension Capital, Fifth Wall, Founder Collective, Founders' Co-op, Founders Fund, Freestyle Capital, Greenoaks Capital, Greylock, Haun Ventures, ICONIQ Capital, Innovation Endeavors, In-Q-Tel, Insight Partners, IVP, Jetstream, Khosla Ventures, Kleiner Perkins, Kluz Ventures, LGF, Long Journey Ventures, Matrix, Paradox Capital, Plaid, Primer Sazze Partners, Scale Venture Partners, Sequoia Capital, Spark Capital, Susa Ventures, The Hit Forge, TSVC Capital, XStarPartners, Yamaha Motor Ventures, Alex Payne, Amjad Masad, Anna Yuan, Austin Walters, Bradley Horowitz, Charles Zedlewski, Cristina Cordova, David Mytton, Dharmesh Shah, DJ Patil, Dylan Field, Gokul Rajaram, Greg Brockman, Guillaume Lestrade, Julie Zhuo, Oleg Rogynskyy, Omar El-Ayat, Ron Pragides, Roxanne Varza, Ryan Chan, Sam Altman, Scott Belsky, Thibaud Elziere, Tobias Lutke, Tony Xu, Young Song
Jun 1, 2022	Euler	$32.0M Venture Round	—	11, Accel, Addition, Craft Ventures, Dimension Capital, Founder Collective, Founders Fund, Haun Ventures, ICONIQ Capital, In-Q-Tel, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, Paradox Capital, Primer Sazze Partners, Sequoia Capital, The Hit Forge, XStarPartners, Amjad Masad, Anna Yuan, Bradley Horowitz, David Mytton, Guillaume Lestrade, Julie Zhuo, Oleg Rogynskyy, Omar El-Ayat, Sam Altman, Tobias Lutke, Tony Xu, Young Song
May 1, 2022	Osmind	$40.0M Series B	—	11, 2xN, Abstract Ventures, Kevin Hartz, Accel, Addition, Alumni Ventures, Amplo, Andreessen Horowitz, Angel investor, Atomic, Audrey Capital, Catalio Capital, Craft Ventures, DFJ Growth, Dimension Capital, Dreamers VC, DST Global, Electric Capital, Founder Collective, Founders Fund, General Catalyst, Haun Ventures, Highbury Group, IA Ventures, ICONIQ Capital, In-Q-Tel, Interlock Partners, Jetstream, Khosla Ventures, LGF, Long Journey Ventures, Lux Capital, Maveron, Menlo Ventures, NewFund, Paradox Capital, Primer Sazze Partners, Quiet Capital, Sequoia Capital, Sonder Capital, Sound Ventures, Susa Ventures, The Hit Forge, Thirty Five Ventures, Ulu Ventures, Union Square Ventures, What If Ventures, WndrCo LLC, XStarPartners, Y Combinator, ZhenFund, Adrian Aoun, Amjad Masad, Anna Yuan, Anne Wojcicki, Brad Bao, Bradley Horowitz, David Mytton, Eric Ries, Guillaume Lestrade, Jared Leto, Jeffrey Lee, Joshua Reeves, Julie Zhuo, Kevin Weil, Marc Benioff, Mike Krieger, Odell Beckham Jr., Oleg Rogynskyy, Omar El-Ayat, Othman Laraki, Sam Altman, Tobias Lutke, Tony Xu, Young Song

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at Avalon Ventures.

Leadership Team

Key people at Avalon Ventures.

Deep Dive

Avalon Ventures - High-Level Overview

Avalon Ventures is a venture capital firm specializing in seed and early-stage investments, primarily in life sciences, wireless communications, Web 3.0 digital media, and information technology sectors. Founded in 1983, the firm focuses on partnering with entrepreneurs to nurture disruptive ideas in dynamic markets, emphasizing a thesis-driven approach to identify innovative companies with strong growth potential. Avalon’s mission centers on supporting transformative technologies that can reshape healthcare and technology landscapes, leveraging its deep industry expertise and entrepreneurial roots. Their impact on the startup ecosystem is significant, having backed over 180 companies, many of which have achieved successful exits, including IPOs, thus fueling innovation and commercialization in their focus sectors[1][2][6].

Origin Story

Avalon Ventures was founded in 1983 and is headquartered in La Jolla, California, with additional presence in Cambridge, Massachusetts. The firm was established by former entrepreneurs, including founder and managing partner Kevin Kinsella, who brought firsthand startup experience to the investment process. Over the decades, Avalon has evolved from a general early-stage investor to a specialized firm with a strong emphasis on life sciences and information technology, including wireless data and Web 3.0 digital media. This evolution reflects the firm’s commitment to staying at the forefront of emerging technology trends and leveraging its network to support companies from seed through Series A and beyond[1][2][7].

Core Differentiators

Unique Investment Model: Avalon focuses on seed and early-stage investments, often being the first institutional investor, which allows it to shape company trajectories from inception.
Network Strength: The firm’s team comprises experienced entrepreneurs and industry veterans, providing portfolio companies with operational guidance and strategic connections.
Track Record: With over 180 investments and multiple successful exits (e.g., Synthorx, Jnana Therapeutics, Kaltura), Avalon has demonstrated consistent ability to identify and grow disruptive startups.
Operating Support: Avalon offers hands-on support beyond capital, including mentorship, industry insights, and partnerships such as its collaboration with GlaxoSmithKline to co-fund life science ventures[1][2][6].

Role in the Broader Tech Landscape

Avalon Ventures rides the wave of several converging trends: the rapid advancement of life sciences (biotech, healthtech), the expansion of wireless communications, and the emergence of Web 3.0 digital media technologies. The timing is critical as these sectors are experiencing accelerated innovation driven by new scientific discoveries, regulatory changes, and increasing digital transformation. Avalon’s early-stage focus positions it to influence the ecosystem by enabling startups to commercialize breakthrough technologies that address unmet needs in healthcare and digital infrastructure. This role helps bridge the gap between research and market-ready solutions, fostering a vibrant innovation economy[1][2][5].

Quick Take & Future Outlook

Looking ahead, Avalon Ventures is likely to deepen its investments in cutting-edge life sciences and emerging Web 3.0 technologies, capitalizing on growing market demand for personalized medicine, AI-driven healthcare, and decentralized digital platforms. Trends such as AI integration in biotech, blockchain applications in media, and 5G/6G wireless expansion will shape their portfolio strategy. Avalon’s influence is expected to grow as it continues to leverage its entrepreneurial expertise and strategic partnerships to accelerate startup success, maintaining its position as a key catalyst in early-stage innovation ecosystems[1][2][6].

Sources

Avalon Ventures - High-Level Overview

Origin Story

Core Differentiators

Unique Investment Model: Avalon focuses on seed and early-stage investments, often being the first institutional investor, which allows it to shape company trajectories from inception.
Network Strength: The firm’s team comprises experienced entrepreneurs and industry veterans, providing portfolio companies with operational guidance and strategic connections.
Track Record: With over 180 investments and multiple successful exits (e.g., Synthorx, Jnana Therapeutics, Kaltura), Avalon has demonstrated consistent ability to identify and grow disruptive startups.
Operating Support: Avalon offers hands-on support beyond capital, including mentorship, industry insights, and partnerships such as its collaboration with GlaxoSmithKline to co-fund life science ventures[1][2][6].